CSIR-SA-001-L2	
    			    			
                CSIRi002-A            
            
        General
Cell Line | 
					|
| hPSCreg name | CSIRi002-A | 
| Cite as: | CSIRi002-A (RRID:CVCL_E3U1) | 
| Alternative name(s) | 
									 
	CSIR-SA-001-L2	 
							 | 
						
| Cell line type | Human induced pluripotent stem cell (hiPSC) | 
| Similar lines | No similar lines found. | 
| Last update | 2nd September 2024 | 
| Notes | Derived from Lonza dermal fibroblasts (Cat# CC-2511, 23801, lot 0000268030) | 
| User feedback | |
Provider | 
					|
| Generator | Council for Scientific and Industrial Research South Africa (CSIR) | 
| Distributors | |
| Derivation country | South Africa | 
External Databases | 
						|
| BioSamples | SAMEA115883343 | 
| Cellosaurus | CVCL_E3U1 | 
							    
							General Information | 
					|
| Publications | |
| * Is the cell line readily obtainable for third parties? | 
                                     No                                                                      | 
                            
Donor Information
General Donor Information | 
					|
| Sex | male | 
| Ethnicity | Black or African American | 
Phenotype and Disease related information (Donor) | 
					|
| Diseases | No disease was diagnosed.
																	 | 
					
Donor Relations | 
							|
| Other cell lines of this donor | |
External Databases (Donor) | 
						|
| BioSamples | SAMEA115889096 | 
Ethics
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes | 
| Was the consent voluntarily given? | Yes | 
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes | 
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | No | 
| Do you (Depositor/Provider) hold the original Donor Consent Form? | No | 
| If you do not hold the Donor Consent Form, do you know who does? | No | 
| Alternatives to consent are available? | Yes | 
| Alternatives to consent | Certificate of analysis from Lonza | 
| Alternative consent approval number | |
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | anonymised | 
| Does consent explicitly allow the derivation of pluripotent stem cells? | No | 
| * Does consent expressly prevent the derivation of pluripotent stem cells? | No | 
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No | 
| How may genetic information associated with the cell line be accessed? | No information | 
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No | 
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes | 
| Name of accrediting authority involved? | CSIR REC | 
| Approval number | 17_2013 | 
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | 
hIPSC Derivation
General | 
						|
| Source cell line name | Lonza cat no. CC-2511 NHDF 23801 Lot No. 0000268030 | 
| Source cell type | 
										
				
	
	
			 Synonyms 
		
  | 
							
| Passage number reprogrammed | 15 | 
Reprogramming method | 
						|
| Vector type | Non-integrating | 
| Vector | Sendai virus | 
| Methods used | 
										 
	RT-PCR	 
									 | 
								
Vector free reprogramming | 
						|
Other | 
						|
| Derived under xeno-free conditions | 
								 No 							 | 
						
| Derived under GMP? | 
								 No 							 | 
						
| Available as clinical grade? | 
								 No 							 | 
						
Culture Conditions
| Surface coating | Matrigel/Geltrex | 
| Passage method | 
								Enzymatically
								
																			 
											TrypLE										 
																	
								
							 | 
						
| Medium | 
								Essential 8™		
		
								 | 
						
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | Yes  | 
					
| Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No  | 
					
| Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | Yes  | 
					
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles | 
| POU5F1 (OCT-4) | 
											 Yes 						                 | 
																                
						                
							                 | 
						                ||||
| NANOG | 
											 Yes 						                 | 
																                
						                
							                 | 
						                ||||
| SOX2 | 
											 Yes 						                 | 
																                
						                
							                 | 
						                
Morphology pictures
Microbiology / Virus Screening | 
						|
| Mycoplasma | Negative | 
Genotyping
Karyotyping (Cell Line) | 
					|
| Has the cell line karyotype been analysed? | 
								 Yes 								
																	
												46, XY
											 
																				
																															
											Passage number: 15											 
																															
											Karyotyping method:
											Molecular karyotype (NGS)											
																						 
																			 | 
						
Other Genotyping (Cell Line) | 
					|

Login to share your feedback, experiences or results with the research community.